Related Experiment Video
Updated: Aug 1, 2026

A High Throughput in situ Hybridization Method to Characterize mRNA Expression Patterns in the Fetal Mouse Lower Urogenital Tract
Published on: August 19, 2011
mRNA and Protein Expression in Human Fetal Membrane Cells: Potential Biomarkers for Preterm Prelabor Rupture of the
Emmeli Mikkelsen1,2, Berthold Huppertz3, Ripudaman Singh4
1Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Blvd. 11, 8200 Aarhus, Denmark.
Abstract:
Clinically, unique markers in fetal membrane cells may contribute to the search for biomarkers for preterm prelabor rupture of the fetal membranes (pPROM) in maternal blood. pPROM is associated with overwhelming inflammation and premature cellular senescence causing "biological microfractures" of the fetal membranes. We hypothesize that these pathological processes are associated with the shedding of fetal membrane cells into the maternal circulation. The aim of this study was to identify markers expressed exclusively in fetal membrane cells to facilitate their isolation, characterization, and determination of biomarker potential in maternal blood. We have (1), by their transcriptomic profile, identified markers that are upregulated in amnion and chorion tissue compared to maternal white blood cells, and (2), by immunohistochemistry, confirmed the localization of the differentially expressed proteins in fetal membranes, placenta, and the placental bed of the uterus. RNA sequencing revealed 31 transcripts in the amnion and 42 transcripts in the chorion that were upregulated. Among these, 22 proteins were evaluated by immunohistochemistry. All but two transcripts were expressed both on mRNA and protein level in at least one fetal membrane cell type. Among these remaining 20 proteins, 9 proteins were not significantly expressed in the villous and extravillous trophoblasts of the placenta.
Insights
Researchers identified unique markers in fetal membrane cells for potential preterm prelabor rupture of the fetal membranes (pPROM) biomarkers. These markers could aid in detecting pPROM by analyzing fetal cells in maternal blood.
Area of Science:
- Reproductive Biology
- Genomics
- Biomarker Discovery
Background:
- Preterm prelabor rupture of the fetal membranes (pPROM) is linked to inflammation and cellular senescence.
- Identifying fetal membrane cell markers could lead to novel biomarkers for pPROM detection in maternal blood.
Purpose of the Study:
- To identify unique markers expressed in fetal membrane cells.
- To assess the potential of these markers for detecting pPROM in maternal circulation.
Main Methods:
- Transcriptomic profiling (RNA sequencing) of amnion and chorion tissues.
- Immunohistochemistry to confirm protein localization in fetal membranes and placenta.
- Comparison of fetal membrane cell markers with maternal white blood cells and placental cells.
Main Results:
- Identified 31 upregulated transcripts in amnion and 42 in chorion compared to maternal white blood cells.
- Confirmed mRNA and protein expression for 20 of the identified markers in fetal membrane cells.
- Found 9 proteins not significantly expressed in placental trophoblasts, suggesting potential specificity.
Conclusions:
- Unique markers in fetal membrane cells show promise as biomarkers for pPROM.
- Further validation is needed to confirm their utility in maternal blood analysis for pPROM diagnosis.
Related Concept Videos
RNA Splicing
Nuclear Export of mRNA
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability

